133 related articles for article (PubMed ID: 22265973)
1. Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity.
Strotmeier J; Willjes G; Binz T; Rummel A
FEBS Lett; 2012 Feb; 586(4):310-3. PubMed ID: 22265973
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
[TBL] [Abstract][Full Text] [Related]
6. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
7. Dominant antigenic peptides located at the heavy chain terminal of botulinum neurotoxin B contain receptor-binding sites for synaptotagmin II.
Shi J; Bao S; Yin J; Cai K; Hou X; Xiao L; Tu W; Wang Q; Wang H
Biochem Biophys Res Commun; 2008 Sep; 374(2):331-5. PubMed ID: 18639519
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER
J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333
[TBL] [Abstract][Full Text] [Related]
10. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.
Rummel A; Eichner T; Weil T; Karnath T; Gutcaits A; Mahrhold S; Sandhoff K; Proia RL; Acharya KR; Bigalke H; Binz T
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):359-64. PubMed ID: 17185412
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.
Berntsson RP; Peng L; Svensson LM; Dong M; Stenmark P
Structure; 2013 Sep; 21(9):1602-11. PubMed ID: 23932591
[TBL] [Abstract][Full Text] [Related]
13. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.
Rummel A; Karnath T; Henke T; Bigalke H; Binz T
J Biol Chem; 2004 Jul; 279(29):30865-70. PubMed ID: 15123599
[TBL] [Abstract][Full Text] [Related]
14. Recombinant luminal domain of human synaptotagmin II in combination with gangliosides inhibits the toxicity of botulinum neurotoxins in mice.
Shi J; Li T; Hou X; Cai K; Bao S; Liu H; Gao X; Xiao L; Tu W; Wang Q; Yin J; Wang H
Microbes Infect; 2010 Apr; 12(4):319-23. PubMed ID: 20080203
[TBL] [Abstract][Full Text] [Related]
15. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
Rummel A
Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
Flores A; Ramirez-Franco J; Desplantes R; Debreux K; Ferracci G; Wernert F; Blanchard MP; Maulet Y; Youssouf F; Sangiardi M; Iborra C; Popoff MR; Seagar M; Fantini J; Lévêque C; El Far O
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):18098-18108. PubMed ID: 31431523
[TBL] [Abstract][Full Text] [Related]
17. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
Rummel A; Mahrhold S; Bigalke H; Binz T
FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
[TBL] [Abstract][Full Text] [Related]
18. Location of the synaptosome-binding regions on botulinum neurotoxin B.
Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
Biochemistry; 2012 Jan; 51(1):316-28. PubMed ID: 22146011
[TBL] [Abstract][Full Text] [Related]
19. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
